CUMULUS NEUROSCIENCE
NeuLogiq Logo

Designed for Use in Clinical Trials with Top 10 Pharma Advisory Group, the NeuLogiq Platform provides frequent, reliable in-clinic and at-home longitudinal monitoring of discrete brain functions.

Cumulus-NeuLogiq-RGB-02-horizontal-color-invert

The NeuLogiq Platform was Designed for Use in Clinical Trials with Top 10 Pharma Advisory Group

Neulogiq provides frequent, reliable in-clinic and at-home longitudinal monitoring of discrete brain functions.

Discover

The NeuLogiq® Platform

Advancing brain health measurement for smarter CNS drug development

A unified platform integrating tablet-based assessments, longitudinal EEG, and real-world data to capture objective neurological change.

Ipad task
Home-use-TabStand-440x290-x2

Designed for Patients

Easy-to-use tools that fit naturally into daily life.

Dashboard—Cirrus-440x290-x2

Built for Researchers

Reliable, repeatable brain function data you can trust.

Home-use-MemMtch-440x290-x2

Made for Real-World Studies

In-clinic and at-home assessments, unified in one platform.

Tablet Based Assessment

Designed for Patients

Easy-to-use measurement tools that patients want to engage with.

Study Management Hub

Built for Researchers

Reliable, repeatable and scalable brain function data you can trust.

Tablet Based Assessment

Made for Real-World Studies

Engaging multi-modal assessments for use in clinic or at home, unified in one platform.

Supporting Decision Making in Clinical Trials

Reliable, longitudinal insights collected in clinic and at home.

Repeat Icon

Repeated Measures

Easy-to-use platform combining low patient burden with high reliability and patient adherence. 

Multi-Modal Icon

Multi-Modal Insights

Incorporate data from multiple modalities such as cognition, EEG, mood, language and sleep.

 Analysis Icon

Full Analysis Pipeline

Built on our reproducible, reliable analysis pipeline using advanced signal processing and machine learning to characterize EEG signals.

What we Measure

The NeuLogiq platform measures multiple domains of brain function to provide a comprehensive view of CNS health and treatment response.

Cognition Icon

Cognition

Tablet-based cognitive assessments designed for repeated, real-world use.

EEG Icon

EEG

Neurophysiological measurements capturing brain network activity, synchronised with behavioural data.

Mood Icon

Mood

EMA (self-reported),
questionnaires

Speech Icon

Speech

Speech rate, output,
pausing behavior 

Sleep Icon

Sleep

Remote measurement of sleep quality and sleep staging using validated third-party tools.

EEG Headset

UKCA-marked and FDA 510(k) cleared medical device, combining regulatory compliance with award-winning design for clinical and research EEG applications.

EEG Headset

Assessment Suite

Comprehensive, multi-modal assessments for both in-clinic and at-home measurement of cognition, neurophysiology and behaviour. Grounded in scientific literature, repeatable and engaging, language-agnostic and suitable for deployment at scale globally.

Assessment Tasks

AI Powered Analytics

Proprietary machine learning-based methods are used to evaluate the multi-dimensional real-world datasets generated through NeuLogiq. These analytics are designed to support exploratory research analysis, enabling the identification of subtle patterns and changes within datasets to inform research hypotheses and trial insights.

Radar Plot

Study Management Hub

Automated, AI-powered dashboards for viewing incoming data from distributed locations across the globe. Provides rapid access to assist in monitoring compliance and data quality of in-clinic and at-home measures. 

Study Management Hub

EEG Headset

UKCA-marked and FDA 510(k) cleared medical device, combining regulatory compliance with award-winning design for clinical and research EEG applications.

NL-headset-3-690x550-x2

Assessment Suite

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

NL-tasks-2-690x550-x2

AI Powered Analytics

Proprietary machine learning-based methods are used to evaluate the multi-dimensional real-world datasets generated through NeuLogiq. These analytics are designed to support exploratory research analysis, enabling the identification of subtle patterns and changes within datasets to inform research hypotheses and trial insights.

NL-analytics-1-690x550-x2

Study Management Hub

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

NL-smh-2-690x550-x2

Research Partners
Biogen Logo Boehringer Logo BMS Logo GSK Logo J&J Logo Lilly Logo MSD Logo Pfizer Logo Roche Logo Takeda Logo

Cumulus Webinars

Explore our webinars archive for insights on how frequent, reliable, longitudinal monitoring of discrete brain functions can accelerate CNS clinical trials and improve decision-making.

Leveraging Digital Biomarkers to Generate Real-World Physiological and Behavioral Data in CNS Clinical Studies- featuringCSO Brian Murphy, PhD and CJ Barnum, VP of CNS Development at INmuneBio
WEBINAR
Leveraging Digital Biomarkers to Generate Real-World Physiological and Behavioral Data in CNS Clinical Studies

Featuring:
- CJ Barnum, VP of CNS Development at INmuneBio
- Tina Sampath, CEO, Cumulus Neuroscience
- Brian Murphy, PhD, Co-founder & CSO, Cumulus Neuroscience

Webinar 5 image
WEBINAR
What if your team could capture objective, physiological and behavioral study data from a diverse group of patients on an ongoing basis, from their own home?

Featuring:
- CJ Barnum, VP of CNS Development at INmuneBio
- Brian Murphy, PhD, Co-founder & CSO, Cumulus Neuroscience

Webinar 4 image
WEBINAR
Case Study: EEG Digital Biomarkers in Neuropsychiatric Clinical Studies

Featuring:
- Snezana Milanovic, MD, MSc, Senior Director, Translational Medicine and Early Development, Sumitomo Pharma America, Inc.
- Alison Buick, PhD, Global Head of Business Development, Cumulus Neurosciencent

Innovations in Alzheimer’s Disease Clinical Trials: Digital Endpoints featuring Ruth McKernan,
WEBINAR
Innovations in Alzheimer’s Disease Clinical Trials: Digital Endpoints

Expert panelists:
- Dr. Ruth McKernan, FMEdSci CBE, Operating Partner, SV Health Investors, CEO, Draig Therapeutics and Chair, Cumulus Neuroscience
- Professor James Rowe, BA BMBCh FRCP PhD, Director of Cambridge Centre for Frontotemporal Dementia and Related Disorders, Department of Clinical Neurosciences, University of Cambridge and Chief Investigator for CNS-101
- Bryan Hansen, Director of Innovative Health, Portfolio Launch Excellence, J&J Innovative Medicine Research & Development
- Brian Murphy, PhD, Co-Founder and CSO, Cumulus Neuroscience

Webinar 2 image
WEBINAR
Neuropsychiatry Clinical Trials: Evolving with Portable EEG and Digital Endpoints

Featuring:
- Aaron Koenig, MD, CMO at Delix Therapeutics
- Brian Murphy, PhD, Co-founder & CSO, Cumulus Neuroscience
- Alison Buick, PhD, Global Head of Business Development, Cumulus Neuroscience

Frequently Asked Questions

Here you can find answers to common questions.

 

Review our publications, posters, video interviews and webinars featuring biopharma customers

Learn How we can Support your Clinical Studies